Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/14/2019
ANI launches generic Aggrenox
Aspirin and extended-release dipyridamole capsules have a market value of roughly $80 million. - 10/13/2019
Bartell Drugs opens new store in Seattle
Bartell Drugs' Belltown location is celebrating its grand opening Saturday, Oct. 19, with prizes, gifts, and savings. - 10/13/2019
Sun Pharma launches Cequa
Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology. - 10/13/2019
Akorn gets FDA nod for betamethasone dipropionate
Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA. - 10/13/2019
Allergan shareholders approve proposed acquisition by AbbVie
Allergan's proposed acquisition by AbbVie is expected to close in early 2020. - 10/10/2019
Eli Lilly gets FDA green light for Reyvow
Eli Lilly's Reyvow is a new option for the acute treatment of migraine. - 10/10/2019
Genoa Healthcare opens 9 new pharmacies across 7 states
Genoa Healthcare is celebrating the recent opening of several new pharmacies across seven states. - 10/10/2019
Schnucks to close 3 St. Louis-area stores
Following three store closures, Schnucks will operate 112 stores, including 82 in the St. Louis metropolitan area. - 10/10/2019
Aclaris Therapeutics divests Rhofade
The divestiture of Rhofade is a key component of Aclaris’ recently announced strategic plan to refocus resources on the development of its immuno-inflammatory development programs. - 10/9/2019
Amneal launches generic Invega
Paliperidone extended-release tablets had a market value of approximately $373 million for the 12 months ended July 31.
